FDA warns of increased risk of rare neurological syndrome associated with Janssen
The Food and Drug Administration is warning of a possible increased risk of a rare neurological condition after getting the Johnson and Johnson COVID-19 vaccine. There are 100 suspected cases of Guillain-Barré syndrome out of the more than 12 million doses given.
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook